When CMS did n’t listen to Price , the congressman unveiled his legislation to delay implementing the regulation until 2018 , with the bill coming days after investing in the company , whose shares were worth Zimmer Biomet’s .59Zimmer Biomet’s the time .   Three months after he introduced the bill , the company